Tech stocks tank but finish off their lows
Biotech stocks, which had been on a tear this year, also pulled back. The iShares Nasdaq Biotechnology ETF (IBB) dropped almost 3%. The sector is considered speculative because investors are in many cases betting on drugs that have yet to be approved.
Stocks bounce back from Monday's tech rout